Skip to main content

Month: May 2020

Myriad Genetics Appoints Daniel K. Spiegelman to the Board of Directors and Announces Upcoming Retirement of John T. Henderson, M.D.

SALT LAKE CITY, May 28, 2020 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN), a global leader in molecular diagnostics and precision medicine, today announced the election of Daniel K. Spiegelman, age 61, to its Board of Directors, effective immediately, expanding the Board to nine members.  Additionally, Mr. Spiegelman was appointed to the audit committee of Myriad’s Board.Mr. Spiegelman has served as a Chief Financial Officer in several diversified biotechnology companies spanning 30 years.  He was most recently Executive Vice President and Chief Financial Officer of BioMarin Pharmaceuticals, Inc., a pharmaceutical company focused on development of first-in-class and best-in-class therapeutics for rare genetic diseases.  Having retired from that position after eight years, Dan now serves on the board of Tizona Therapeutics,...

Continue reading

360 Finance Announces First Quarter 2020 Unaudited Financial Results

SHANGHAI, China, May 28, 2020 (GLOBE NEWSWIRE) — 360 Finance, Inc. (QFIN) (“360 Finance” or the “Company”), a leading digital consumer finance platform, today announced its unaudited financial results for the first quarter ended March 31, 2020.First Quarter Operational HighlightsTotal loan origination volume*1 was RMB51,770 million, representing an increase of 25.6% from RMB41,202 million in the same period of 2019. Loan origination volume for Credit Driven Services was RMB40,866 million, including RMB31,941 million for off-balance-sheet loans and RMB8,925 million for on-balance-sheet loans, compared to RMB40,862 million, RMB38,789 million and RMB2,073 million in the same period of 2019, respectively. Loan origination volume under capital-light model within Platform Services was RMB10,904 million, an increase of 3107.1% from RMB340...

Continue reading

Keros Therapeutics To Present At The Jefferies 2020 Virtual Healthcare Conference

LEXINGTON, Mass., May 28, 2020 (GLOBE NEWSWIRE) — Keros Therapeutics, Inc. (“Keros”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need, today announced that Keros’ President and Chief Executive Officer Jasbir S. Seehra, Ph.D. is scheduled to present at the Jefferies Virtual Healthcare Conference on Thursday, June 4, 2020 at 9:00 am ET.About Keros Therapeutics, Inc.Keros is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel treatments for patients suffering from hematologic and musculoskeletal disorders with high unmet medical need. Keros is a leader in understanding the role of the...

Continue reading

Seelos Therapeutics Announces Initiation of Preclinical Study of SLS-004 in Parkinson’s Disease

NEW YORK, May 28, 2020 (GLOBE NEWSWIRE) — Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, today announced the initiation of a preclinical study of SLS-004 in Parkinson’s disease (PD) through an all-in-one lentiviral vector targeting the synuclein alpha (SNCA) gene.

Continue reading

Steve Madden Announces First Quarter 2020 Results

LONG ISLAND CITY, N.Y., May 28, 2020 (GLOBE NEWSWIRE) — Steve Madden (Nasdaq: SHOO), a leading designer and marketer of fashion-forward footwear, accessories and apparel for women, men and children, today announced financial results for the first quarter ended March 31, 2020.Amounts referred to as “Adjusted” exclude the items that are described under the heading “Non-GAAP Adjustments.”The Company reclassified commission and licensing fee income to Total Revenue and reclassified its respective expenses into Operating Expenses from previously labeled Commission and Licensing Fee Income – Net on the Company’s Consolidated Statement of Operations for each period provided.First Quarter 2020 ReviewRevenue decreased 13.6% to $359.2 million compared to $415.8 million in the same period of 2019.Gross margin was 37.2% compared...

Continue reading

Golden Minerals Announces Sedar Filing of Preliminary Economic Assessment for Rodeo Gold Project

GOLDEN, Colo., May 28, 2020 (GLOBE NEWSWIRE) — Golden Minerals Company (NYSE American and TSX: AUMN) (“Golden Minerals”, “Golden” or “the Company”) is pleased to announce the filing on SEDAR of a Preliminary Economic Assessment (“PEA”) and accompanying Technical Report for its Rodeo open pit gold project. Rodeo is located in Durango State, Mexico approximately 80 kilometers west of the Company’s Velardeña Properties. The report is dated May 27, 2020 and has been prepared in accordance with National Instrument 43-101 Standards of Disclosure for Mineral Projects by the independent firm of Mineral Resources Engineering.The Technical Report is available for review on SEDAR (www.sedar.com) and on the Company’s website at https://www.goldenminerals.com/projects/technical-reports/Qualified PersonsThe Report was prepared by the following...

Continue reading

Endeavour Silver Restarts Mining Operations in Mexico

VANCOUVER, British Columbia, May 28, 2020 (GLOBE NEWSWIRE) — Endeavour Silver Corp. (NYSE: EXK) (TSX: EDR) announces that it has restarted mining operations at its three high-grade, underground silver-gold mines in Mexico.  The Company filed its mine operating and health plans with, and received approvals from, the Secretariat of Health in Mexico to recommence mining operations.Management developed its mine restart plan utilizing the rigorous virus monitoring, prevention and response measures already in place at our three mines that comply with government mandated practices to ensure a safe working environment for all employees. At each site, Endeavour’s actions to protect its people, communities and business include:All employees and contractors reporting for duty undergo medical screening to verify that no one with COVID-19 symptoms...

Continue reading

Titan Machinery Inc. Announces Results for Fiscal First Quarter Ended April 30, 2020

– Revenue for First Quarter of Fiscal 2021 Increased 11.5% to $310.2 million –– GAAP EPS for First Quarter of Fiscal 2021 was $0.10 and Adjusted EPS was $0.15 –– Enters into a New Five-year Amended and Restated Credit Agreement –– Closes Domestic Acquisition of HorizonWest Dealership Complex –WEST FARGO, N.D., May 28, 2020 (GLOBE NEWSWIRE) — Titan Machinery Inc. (Nasdaq: TITN), a leading network of full-service agricultural and construction equipment stores, today reported financial results for the fiscal first quarter ended April 30, 2020.David Meyer, Titan Machinery’s Chairman and Chief Executive Officer, stated, “We are pleased to report a strong first quarter performance during this uncertain environment, driven by our continued focus on customer service and sound management...

Continue reading

Burlington Stores, Inc. Reports First Quarter 2020 Earnings

On a GAAP basis, total sales declined 51%, net loss was $334 million, and EPS was ($5.09).On a Non-GAAP basis, Adjusted EPS was ($4.76), which includes a $272 million charge, or $2.77 per share, against aged inventory. This reserve covers the full cost of markdowns that are expected to be taken on this aged inventory in the second quarter.All stores were closed by March 22, 2020, but began to re-open on May 11, 2020; since re-opening, sales in re-opened stores have exceeded prior year levels.Expect to have 402 stores re-opened by May 29, 2020, and most of the balance of the chain re-opened by mid-June 2020.BURLINGTON, N.J., May 28, 2020 (GLOBE NEWSWIRE) — Burlington Stores, Inc. (NYSE: BURL), a nationally recognized off-price retailer of high-quality, branded apparel, footwear, accessories, and merchandise for the home at everyday...

Continue reading

Formula Systems Reports First Quarter 2020 Financial Results

Operating income for the first quarter increased 22% year-over-year to a record breaking $38.8 million. Net income attributable to Formula’s Shareholders for the first quarter increased 10% year-over-year to a record breaking $11.0 million.OR YEHUDA, Israel, May 28, 2020 (GLOBE NEWSWIRE) — Formula Systems (1985) Ltd. (NASDAQ: FORTY), a global information technology holding company engaged, through its subsidiaries and affiliates, in providing software consulting services and computer-based business solutions and developing proprietary software products, today announced its results for the first quarter ended March 31, 2020.Financial Highlights for the First Quarter Ended March 31, 2020Consolidated revenues for the first quarter increased by 19.1% to a record breaking $466.3 million, with growth recorded across Formula’s entire investment...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.